cephalosporin c has been researched along with Mycoplasma dispar Infection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckburg, PB; File, TM; Friedland, HD; Llorens, L; Talbot, GH | 1 |
Chávez-Bueno, S; Fonseca-Aten, M; Gómez, AM; Hardy, RD; Hatfield, J; Jafri, HS; Katz, K; McCracken, GH; Mejías, A; Ramilo, O; Ríos, AM | 1 |
Holzleitner, P; Königswieser, H; Stögmann, W | 1 |
Dalquen, P; Gonon, M; Perruchoud, AP; Zimmerli, W | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
6 other study(ies) available for cephalosporin c and Mycoplasma dispar Infection
Article | Year |
---|---|
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Chlamydial Pneumonia; Chlamydophila pneumoniae; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2017 |
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Topics: Airway Obstruction; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cephalosporins; Chemokines; Cytokines; Erythromycin; Ketolides; Lung; Mice; Mycoplasma pneumoniae; Plethysmography; Pneumonia, Mycoplasma; Respiratory Mechanics; Respiratory Tract Infections | 2004 |
[Mycoplasma pneumoniae-pneumonia in childhood (author's transl)].
Topics: Adolescent; Cephalosporins; Child; Child, Preschool; Cough; Doxycycline; Female; Hepatitis; Humans; Infant; Infant, Newborn; Lung; Male; Nephritis; Pneumonia, Mycoplasma; Radiography | 1982 |
[Therapeutic problems in pneumonia].
Topics: Adult; Amoxicillin; Bronchoalveolar Lavage Fluid; Cephalosporins; Clavulanic Acids; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Middle Aged; Pneumonia; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Pneumonia, Viral; Pulmonary Alveolar Proteinosis | 1995 |
The choice of antibacterial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Neutropenia; Penicillins; Pneumonia, Mycoplasma; Pneumonia, Staphylococcal; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |